Satellos Bioscience, Inc.
3 clinical trials · Sponsor
◉ Watch Satellos Bioscience, Inc.
| Record | Firm | Date |
|---|---|---|
| Phase 2 Study of SAT-3247 in Pediatric Ambulatory Patients (NCT07287189) | Satellos Bioscience, Inc. | 2025-12-08 |
| An Open-label Long-term Follow-up Study of SAT-3247 for Participants With Duchenne Muscular Dystrophy Including Those Who Participated in SAT-3247-CL-101 (NCT06867107) | Satellos Bioscience, Inc. | 2025-08-20 |
| First in Human SAD/MAD Safety and PK Study With Adult DMD Safety and PK Cohort (NCT06565208) | Satellos Bioscience, Inc. | 2024-08-21 |
Track Satellos Bioscience, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.